Adaptive Optics in PVR

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the loss of retinal cells following retinal detachment surgery using an imaging device called an adaptive optics camera. The retina is a thin layer which lines the back of the eye. It is sensitive to light (like the film in a camera) and is necessary for vision. If a hole or rip develops in a retina it can become detached. The macula is the central portion of the retina which the investigators use for fine vision. This area can also become detached as part of a retinal detachment. Proliferative vitreoretinopathy (PVR) is an abnormal scarring response inside the eye which can occur when the retina detaches. It can adversely affect the outcome of the retinal detachment repair and is associated with a worse visual prognosis. The investigators want to investigate retinal cell loss in patients with retinal detachments that have developed PVR when the macula has been involved.

The investigators plan to compare them to two other groups of patients, who have not developed PVR:

1. Patients with macula-involving retinal detachments without PVR

2. Patients with macula-sparing detachments without PVR

The investigators will investigate retinal cell loss in these types of retinal detachments using adaptive optics imaging. This is a non-invasive imaging technique which allows the investigators to view the retina at very high magnification. Investigating photoreceptor loss and its association with visual outcome in this way should help to guide future interventions in promoting retinal regeneration. The investigators plan to recruit 25 patients at one UK hospital. The project is funded by the charity Fight for Sight.

Clinical Trial Description

A cohort of 10 cases of macula-involving retinal detachment complicated by proliferative vitreoretinopathy grade C (RDPVR group) will be identified from vitreoretinal clinics at Moorfields Eye Hospital. 26 weeks following retinal detachment repair, and after removal of any silicone oil tamponade, these cases will undergo post-operative visual assessment, OCT imaging and microperimetry. These investigations will be correlated with adaptive optics (AO) enface imaging of cone photoreceptors at the macula. This will be compared with groups of 10 cases of macula involving retinal detachment without PVR (RD-OFF) and 5 cases of macula-sparing retinal detachment (RD-ON). Both comparison groups (RD-OFF & RD-ON) will undergo assessments at both 6 weeks and 26 weeks post-operatively. ;

Study Design

Related Conditions & MeSH terms

Retinal Detachment

Clinical Trial Details

NCT number	NCT03551574
Study type	Observational
Source	Moorfields Eye Hospital NHS Foundation Trust
Contact
Status	Completed
Phase
Start date	April 13, 2017
Completion date	June 4, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed	`NCT03660384` - Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Recruiting	`NCT05863312` - REtinal Detachment Outcomes Study	N/A
Recruiting	`NCT05561569` - Air Versus Gas Tamponade in Primary Retinal Detachment	N/A
Not yet recruiting	`NCT05538156` - Internal Limiting Membrane Peeling in Retinal Detachment Surgery	N/A
Completed	`NCT03046719` - Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal	N/A
Recruiting	`NCT01261533` - Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment	Phase 1
Terminated	`NCT02068625` - Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment	Phase 4
Completed	`NCT00000140` - The Silicone Study	Phase 3
Recruiting	`NCT05543018` - Effect of Intraocular Tamponade on Visual Perception	N/A
Not yet recruiting	`NCT04518696` - Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment	N/A
Completed	`NCT03321253` - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification	N/A
Completed	`NCT06166914` - Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment	N/A
Enrolling by invitation	`NCT05566626` - Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera	N/A
Not yet recruiting	`NCT03631108` - Feasibility Study and Preliminary Application Study on Iris OCTA
Recruiting	`NCT02201706` - Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye	N/A
Completed	`NCT03218371` - Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.	N/A
Completed	`NCT00000154` - Diabetic Retinopathy Vitrectomy Study (DRVS)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.